Efficacy and safety of subcutaneous L-dopa/carbidopa (ND0612H) infusion in fluctuating PD patients

被引：0
|
作者：
Olanow, C. Warren [1 ]
Stocchi, Fabrizio [2 ,3 ]
Poewe, Werner [4 ]
Ellenbogen, Aaron [5 ,6 ]
Djaldetti, Ruth [7 ]
Minei, Tami Rachmilewitz [8 ]
Cohen, Yael [8 ]
Oren, Sheila [8 ]
Kieburtz, Karl [9 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Univ Rome, Rome, Italy
[3] IRCCS San Raffaele Roma, Rome, Italy
[4] Univ Hosp Neurol, Innsbruck, Austria
[5] Michigan Inst Neurol Disorders, Farmington Hills, CT USA
[6] Quest Res Inst, Farmington Hills, CT USA
[7] Tel Aviv Univ, Petah Tiqwa, Israel
[8] NeuroDerm, Rehovot, Israel
[9] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S26.003
引用
收藏
页数：3
相关论文
共 27 条
  • [11] CONTINUOUS SUBCUTANEOUS LEVODOPA/CARBIDOPA INFUSION (ND0612) FOR PATIENTS WITH PARKINSON'S DISEASE AND MOTOR FLUCTUATIONS: A PHASE 3, ACTIVE-CONTROLLED STUDY (BOUNDLESS)
    Stocchi, F.
    Espay, A.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J. J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Yardeni, T.
    Adar, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Rascol, O.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [12] ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
    Giladi, Nir
    Gurevich, Tanya
    Djaldetti, Ruth
    Adar, Liat
    Case, Ryan
    Leibman-Barak, Shelly
    Sasson, Nissim
    Caraco, Yoseph
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 139 - 145
  • [13] Early onset of efficacy of safinamide on motor fluctuations in PD patients on L-dopa and other PD medications (SETTLE study)
    Anand, R.
    Lucini, V.
    Forrest, E.
    Giuliani, R.
    Suresh, A.
    MOVEMENT DISORDERS, 2014, 29 : S224 - S224
  • [14] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial
    Espay, Alberto J.
    Stocchi, Fabrizio
    Pahwa, Rajesh
    Albanese, Alberto
    Ellenbogen, Aaron
    Ferreira, Joaquim J.
    Giladi, Nir
    Gurevich, Tanya
    Hassin-Baer, Sharon
    Hernandez-Vara, Jorge
    Isaacson, Stuart H.
    Kieburtz, Karl
    Lewitt, Peter A.
    Lopez-Manzanares, Lydia
    Olanow, C. Warren
    Poewe, Werner
    Sarva, Harini
    Yardeni, Tami
    Adar, Liat
    Salin, Laurence
    Lopes, Nelson
    Sasson, Nissim
    Case, Ryan
    Rascol, Olivier
    LANCET NEUROLOGY, 2024, 23 (05) : 465 - 476
  • [15] Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study
    Isaacson, S.
    Giladi, N.
    Stocchi, F.
    Salin, L.
    Vostokova, N.
    Poewe, W.
    MOVEMENT DISORDERS, 2022, 37 : S334 - S334
  • [16] The iNDiGO study: A multicenter, randomized, double-blind, placebo-controlled clinical study investigating the efficacy, tolerability, and safety of two dosing regimens of continuous subcutaneous ND0612 infusion given as adjunct treatment to oral levodopa in fluctuating PD
    Kieburtz, Karl
    Olanow, C. Warren
    Minei, Tami Rachmilewitz
    Cohen, Yael
    Oren, Sheila
    NEUROLOGY, 2018, 90
  • [17] ND0612, a novel liquid formulation of levodopa/carbidopa for subcutaneous infusion in patients with Parkinson's disease achieves stable levodopa plasma levels when administered in low and high doses
    Giladi, Nir
    Caraco, Yoseph
    Gurevich, Tanya
    Djaldetti, Ruth
    Adar, Liat
    Cohen, Yael
    Minei, Tamar Rachmilewitz
    Oren, Sheila
    NEUROLOGY, 2017, 88
  • [18] BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Barak, S. Leibman
    Adar, L.
    Rosenfeld, O.
    Olanow, C. W.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E53 - E53
  • [19] Continuous Subcutaneous Levodopa/Carbidopa Infusion With ND0612 For Patients With Parkinson's Disease And Motor Fluctuations: Results From The Phase 3 Randomized, Active-Controlled BouNDless Study
    Rascol, O.
    Albanese, A.
    Ellenbogen, A.
    Ferreira, J.
    Giladi, N.
    Gurevich, T.
    Hassin-Baer, S.
    Hernandez-Vara, J.
    Isaacson, S.
    Kieburtz, K.
    LeWitt, P.
    Lopez-Manzanares, L.
    Olanow, C. W.
    Pahwa, R.
    Poewe, W.
    Sarva, H.
    Stocchi, F.
    Yardeni, T.
    Adar, L.
    Salin, L.
    Lopes, N.
    Sasson, N.
    Case, R.
    Espay, A.
    MOVEMENT DISORDERS, 2023, 38 : S4 - S4
  • [20] COMPARATIVE EFFICACY OF 2 ORAL SUSTAINED-RELEASE PREPARATIONS OF L-DOPA IN FLUCTUATING PARKINSONS-DISEASE - PRELIMINARY FINDINGS IN 20 PATIENTS
    KLEEDORFER, B
    POEWE, W
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (02) : 173 - 178
123